[go: up one dir, main page]

PE20010166A1 - Nuevas oxazolidinonas biciclicas como agentes antibacterianos - Google Patents

Nuevas oxazolidinonas biciclicas como agentes antibacterianos

Info

Publication number
PE20010166A1
PE20010166A1 PE2000000486A PE0004862000A PE20010166A1 PE 20010166 A1 PE20010166 A1 PE 20010166A1 PE 2000000486 A PE2000000486 A PE 2000000486A PE 0004862000 A PE0004862000 A PE 0004862000A PE 20010166 A1 PE20010166 A1 PE 20010166A1
Authority
PE
Peru
Prior art keywords
alkyl
methyl
oxazolidinones
oxazolidin
indol
Prior art date
Application number
PE2000000486A
Other languages
English (en)
Inventor
Hester
Michael J Genin
Michael R Barbachyn
Paul D Johnson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20010166A1 publication Critical patent/PE20010166A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

SE REFIERE A OXAZOLIDINONAS BICICLICAS DE FORMULA I, DONDE: W ES O, S; X ES S(=O)m, NR3; Y ES O, NH, CH2, S(=O)m; R1 ES ALQUILO C1-C4 OPCIONALMENTE SUSTITUIDO CON R5; R2 ES H, ALQUILO C1-C6, CICLOPROPILO, NH2, NH-ALQUILO C1-C6, ENTRE OTROS; R3 ES ALQUILO C1-C8, C(=O)R4, C(=S)NHALQUILO C1-4; R4 ES H, ALQUILO C1-C6, CH2OC(=O)ALQUILO C1-C4; R5 ES HALOGENO, CN, OH, SH, NH2, OR6, ENTRE OTROS; R6 ES ALQUILO C1-C6, C(=O)ALQUILO C1-C4; C(=O)OALQUILO C1-C4, C(=O)NH2, C(=O)NHALQUILO C1-C4, SO2-ALQUILO C1-C4; m ES 0-2; n ES 0-1; CON LA CONDICION QUE CUANDO n ES 0, Y ES -CH2-. SON COMPUESTOS PREFERIDOS N-({(5S)-3-[(2R)-1-(2-FLUOROETIL)-2-METIL-2,3-DIHIDRO-1H-INDOL-5-IL]-2-OXO-1,3-OXAZOLIDIN-5-IL}METIL)ACETAMIDA; N-{[(5S)-3-((2R)-1-GLICOLIL-2-METIL-2,3-DIHIDRO-1H-INDOL-5-IL)-2-OXO-1,3-OXAZOLIDIN-5-IL]METIL}ACETAMIDA, N-({(5S)-3-[(2R)-1-FORMIL-2-METIL-2,3-DIHIDRO-1H-INDOL-5-IL]-2-OXO-1,3-OXAZOLIDIN-5-IL}METIL)ETANOTIOAMIDA, ENTRE OTROS. EL COMPUESTO I ES UN ANTIMICROBIANO, UTILIZANDOSE 0,1 mg/Kg A 100 mg/kg DE PESO CORPORAL/DIA Y PUEDEN SER UTILES PARA EL TRATAMIENTO DE INFECCIONES MICROBIANAS CUTANEAS, OCULARES
PE2000000486A 1999-05-27 2000-05-23 Nuevas oxazolidinonas biciclicas como agentes antibacterianos PE20010166A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13625099P 1999-05-27 1999-05-27

Publications (1)

Publication Number Publication Date
PE20010166A1 true PE20010166A1 (es) 2001-02-03

Family

ID=22472021

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000486A PE20010166A1 (es) 1999-05-27 2000-05-23 Nuevas oxazolidinonas biciclicas como agentes antibacterianos

Country Status (20)

Country Link
US (2) US6387896B1 (es)
EP (1) EP1181288B1 (es)
JP (1) JP2003501351A (es)
KR (1) KR20020012245A (es)
CN (1) CN1142162C (es)
AR (1) AR024118A1 (es)
AT (1) ATE246189T1 (es)
AU (1) AU767380B2 (es)
BR (1) BR0010982A (es)
CA (1) CA2372233A1 (es)
DE (1) DE60004207T2 (es)
DK (1) DK1181288T3 (es)
ES (1) ES2203473T3 (es)
HK (1) HK1046680B (es)
MX (1) MXPA01012167A (es)
NZ (1) NZ515754A (es)
PE (1) PE20010166A1 (es)
PT (1) PT1181288E (es)
WO (1) WO2000073301A1 (es)
ZA (1) ZA200109384B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0010982A (pt) * 1999-05-27 2002-03-05 Upjohn Co Novas oxazolidinonas bicìclicas como agentes antibacterianos
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6642238B2 (en) 2000-02-10 2003-11-04 Pharmacia And Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
WO2001058885A1 (en) * 2000-02-10 2001-08-16 Pharmacia & Upjohn Company Oxazolidinone thioamides with piperazine amide substituents
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
HK1054325B (zh) * 2000-03-22 2006-01-13 法玛西雅厄普约翰美国公司 恶唑烷酮片剂的配方
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
PE20020689A1 (es) 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
AU2005270951A1 (en) * 2004-08-06 2006-02-16 Pharmacia & Upjohn Company Llc Oxazolidinones containing oxindoles as antibacterial agents
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
KR20070116989A (ko) * 2005-04-06 2007-12-11 파마시아 앤드 업존 캄파니 엘엘씨 항균제로서의 옥신돌 옥사졸리디논
TW200804288A (en) * 2005-12-12 2008-01-16 Astrazeneca Ab Alkylsulphonamide quinolines
RU2522582C2 (ru) 2008-11-20 2014-07-20 Панацеа Биотек Лтд. Новые противомикробные средства
RU2012102094A (ru) 2009-06-26 2013-08-10 Панацеа Биотек Лтд. Новые азабициклогексаны

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8506659A1 (es) * 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
US5032605A (en) 1987-10-09 1991-07-16 Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5036093A (en) 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
US5039690A (en) 1987-10-09 1991-08-13 Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5036092A (en) 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
EP0609905B1 (en) 1988-09-15 2001-06-06 PHARMACIA & UPJOHN COMPANY 3-(Nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
ZA968661B (en) 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
BR0010982A (pt) * 1999-05-27 2002-03-05 Upjohn Co Novas oxazolidinonas bicìclicas como agentes antibacterianos

Also Published As

Publication number Publication date
BR0010982A (pt) 2002-03-05
ATE246189T1 (de) 2003-08-15
WO2000073301A1 (en) 2000-12-07
HK1046680A1 (en) 2003-01-24
AU767380B2 (en) 2003-11-06
PT1181288E (pt) 2003-12-31
EP1181288B1 (en) 2003-07-30
EP1181288A1 (en) 2002-02-27
KR20020012245A (ko) 2002-02-15
CN1353709A (zh) 2002-06-12
ZA200109384B (en) 2003-02-14
JP2003501351A (ja) 2003-01-14
DE60004207D1 (de) 2003-09-04
ES2203473T3 (es) 2004-04-16
CN1142162C (zh) 2004-03-17
DK1181288T3 (da) 2003-11-17
CA2372233A1 (en) 2000-12-07
AU4797500A (en) 2000-12-18
AR024118A1 (es) 2002-09-04
US6387896B1 (en) 2002-05-14
DE60004207T2 (de) 2004-06-03
NZ515754A (en) 2003-10-31
US20020143009A1 (en) 2002-10-03
MXPA01012167A (es) 2002-06-21
HK1046680B (zh) 2004-12-31

Similar Documents

Publication Publication Date Title
PE20010166A1 (es) Nuevas oxazolidinonas biciclicas como agentes antibacterianos
PE20090160A1 (es) COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
ATE314365T1 (de) Cyanopyrrole als progesteronrezeptoragonisten
PT1030852E (pt) Derivados de oxazolidinona e composicoes farmaceuticas
BR0008173A (pt) Composto de amida e seu uso como campo técnico de medicina da invenção
PE20020917A1 (es) Derivados de imidazol como bloqueadores del receptor n-metil-d-aspartato
PE20050420A1 (es) Fenacilo 2-hidroxi-3-diaminoalcanos
PE46899A1 (es) Derivados de n-fenil-sulfonamida
ATE211466T1 (de) Depsipeptide, herstellung und anwendung
PE20010544A1 (es) Derivados de mutilina utiles como agentes antibacterianos
SI9620111B (en) Imidazole derivatives having affinity for alpha2 receptors activity
RU2002103219A (ru) Производные мутилинов и их применение в качестве антибактериальных средств
PE20010634A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
PE20040762A1 (es) Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
CL2003002050A1 (es) Compuestos derivados de 1-piperazin-1,2-dihidroindeno, su composicion farmaceutica y el uso de esta para tratar enfermedades del sistema nervioso central.
PE20051054A1 (es) Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento
PE41796A1 (es) Compuesto activo en el receptor de serotonina 5-ht, util en el tratamiento de enfermedades del s.n.c.
SE9903997D0 (sv) New compounds
NO924783D0 (no) Terapeutiske midler
GEP20084306B (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
PE20011124A1 (es) Nuevos agentes antibacterianos de benzosultam oxazolidinona
KR920018030A (ko) 치환된 이미다졸-2-온의 유도체 및 이의 제조방법
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
PE20011230A1 (es) Derivados de imidazol como agonistas de alfa- 2- adrenoreceptores
PE20060619A1 (es) Derivados de oxazolidinona como antibacterianos

Legal Events

Date Code Title Description
FC Refusal